Roche and Ascidian agree to $1.8bn neurological disease partnership
Researchers identify new major cause of inflammatory bowel disease
UCB’s Bimzelx approved by MHRA for hidradenitis suppurativa
The evolutionary lessons for Bayer’s management restructure